Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.
about
Looking back at 10 years of trastuzumab therapy: what is the role of HER2 testing? A systematic review of health economic analyses.Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injuryA plant-expressed conjugate vaccine breaks CD4(+) tolerance and induces potent immunity against metastatic Her2(+) breast cancer.Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.Principles of a risk evaluation and mitigation strategy (REMS) for breast cancer patients receiving potentially cardiotoxic adjuvant treatments.Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment.Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity?Imaging and chemotherapy cardiotoxicity: A long-playing story still seeking precision and improved outcomes/management data.Cardiac risk associated with the receipt of anthracycline and trastuzumab in a large nationwide cohort of older women with breast cancer, 1998-2005.
P2860
Q34022527-1EB39046-08B5-410E-95E1-C27194AB71C0Q35039202-40E7B18E-C45F-4885-8A5F-3326484BCAB5Q37078963-49A3924E-2484-4FBA-90AE-51B74B4E3731Q38735433-361B98E8-E4BB-4349-844F-6355EABD1F95Q38786052-5414267E-A9F9-4A9D-8BD4-F3CBEC0C3C80Q41704131-700F7DAB-D052-4DE9-9A75-7A7ACBEBFB9FQ41771261-BF4997FB-BCD2-485D-B61C-210CA718A170Q44046843-AF714794-12B9-477D-8F82-FCD5D408C210Q44868340-2BDBE95C-3230-44F9-AD63-DB18F12E39CB
P2860
Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.
@en
Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.
@nl
type
label
Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.
@en
Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.
@nl
prefLabel
Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.
@en
Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.
@nl
P2093
P2860
P1476
Cardiotoxicity associated with the use of trastuzumab in breast cancer patients
@en
P2093
Dirk J van Veldhuisen
Dirk T Sleijfer
Maarten Alexander de Korte
Patrick J Perik
P2860
P304
P356
10.1586/14737140.7.12.1763
P577
2007-12-01T00:00:00Z